Spegra (Descovy + Tivicay)

USD $87.00

Spegra™ (30 tabs) is a licensed generic of Descovy® + Tivicay® (Tenofovir Alafenamide / Emtricitabine + Dolutegravir) which are U.S. FDA approved prescription HIV medicines that are used in combination as a complete treatment regimen for HIV-1. This three-drug combination will soon be the new WHO first line recommended treatment for HIV-1.